This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Luka Krampert: Innovator in Antiviral Research
Introduction
Luka Krampert is a notable inventor based in Regensburg, Germany. He has made significant contributions to the field of antiviral research, particularly through his innovative patent. His work focuses on developing antiviral agents that can combat viral infections, including those caused by coronaviruses and flaviviruses.
Latest Patents
Krampert holds a patent titled "Antiviral agents, uses thereof and methods for their preparation." This patent details the use of cladoniamides and their derivatives as antiviral agents. The disclosure emphasizes the potential of these compounds in treating viral infections, showcasing Krampert's commitment to advancing medical science.
Career Highlights
Luka Krampert is affiliated with the University of British Columbia, where he continues to engage in groundbreaking research. His academic background and professional endeavors have positioned him as a key figure in the field of antiviral drug development.
Collaborations
Krampert collaborates with François Jean, enhancing the scope and impact of his research. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Luka Krampert's contributions to antiviral research through his patent and collaboration with François Jean highlight his dedication to improving public health. His work is a testament to the vital role of inventors in addressing global health challenges.